CRT-D Based Impedance Monitoring Study

• To assess the use of the impedance feature in conjunction with other functions of the CRT-D device [ Time Frame: 6 months ]
• To collect intra-thoracic lead impedance data on up to six impedance vectors [ Time Frame: 6 months ]

The intent of this feasibility study is to collect and analyze intra-thoracic impedance measurements from a CRT-D device in a heart failure population.

This is a multi-center feasibility study intended to collect information on changes in intra-thoracic impedance measurements from CRT-D devices. In order to obtain an intra-thoracic impedance measurement, the device delivers a subthreshold impulse that measures the resistance between two electrodes.

At the programmed interval, measurements will be obtained between six different lead configurations.

Inclusion Criteria:

Eligible patients will meet all of the following:

1. Have an approved indication per ACC/AHA/HRS guidelines for implantation of a CRT-D or have a previously implanted SJM CRT-D system capable of enabling the diagnostic impedance monitoring feature with implant occurring within the last 14 days
2. Have had at least one hospitalization, emergency department visit, or clinic visit within the past 12 months for treatment of decompensated heart failure requiring intravenous diuretics, intravenous inotropes, Natrecor (Nesiritide) therapy, or an increase in an oral diuretic of ≥100% over a 24 hour period
3. Have the ability to maintain a patient diary for recording daily weights, symptoms related to HF, changes in diuretic therapy, and any unscheduled clinic or hospital visits
4. Have the ability to provide informed consent for study participation and be willing and able to comply with the prescribed follow-up tests and schedule of evaluation

Exclusion Criteria:

Patients will be excluded if they meet any of the following:

1. Be less than 18 years of age
2. Have had a recent myocardial infarction, unstable angina or cardiac revascularization (PTCA/stent(s) or CABG) within 40 days of enrollment
3. Have had a recent CVA or TIA within three months of enrollment
4. Have a contraindication for an emergency thoracotomy
5. Have an indication that requires programming device in AAI pacing mode
6. Have permanent (chronic) atrial fibrillation
7. Have a capped or inactive RA or RV pacing/defibrillator lead
8. Have a hypersensitivity to a single 1.0mg dose of dexamethasone sodium phosphate or short term contact with heparin
9. Be pregnant or planning a pregnancy in the next 6-months
10. Be currently participating in a clinical investigation that includes an active treatment arm
11. Have a life expectancy of less than six months due to any condition